-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 RGm1GAS8YI5RA29HYFCf89IGdLWCBVtdSBJP1sCXSB2BnI/90HKV3ztHLeDRWfTQ
 SLtclMCBa0Ctua1mjZNP/Q==

<SEC-DOCUMENT>0001144204-05-033458.txt : 20051101
<SEC-HEADER>0001144204-05-033458.hdr.sgml : 20051101
<ACCEPTANCE-DATETIME>20051101143513
ACCESSION NUMBER:		0001144204-05-033458
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20051031
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20051101
DATE AS OF CHANGE:		20051101

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARGAN INC
		CENTRAL INDEX KEY:			0000100591
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				131947195
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0131

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31756
		FILM NUMBER:		051169370

	BUSINESS ADDRESS:	
		STREET 1:		ONE CHURCH STREET
		STREET 2:		SUITE 302
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		301 315-0027

	MAIL ADDRESS:	
		STREET 1:		ONE CHURCH STREET
		STREET 2:		SUITE 302
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PUROFLOW INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ULTRA DYNAMICS CORP
		DATE OF NAME CHANGE:	19830522
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v028103_8-k.txt
<TEXT>

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                -----------------

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of report (Date of earliest event reported): October 31, 2005


                                   ARGAN, INC.
             (Exact Name of Registrant as Specified in its Charter)


         Delaware                       001-31756                 13-1947195
(State or Other Jurisdiction           (Commission              (IRS Employer
      of Incorporation)               File Number)           Identification No.)


One Church Street, Suite 302, Rockville, MD                         20850
   (Address of Principal Executive Offices)                       (Zip Code)


Registrant's telephone number, including area code: (301) 315-0027


                                 Not Applicable
          (Former Name or Former Address, if Changed Since Last Report)


      Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))


<PAGE>

Item 8.01  Other Events.

On October 31, 2005, Argan, Inc. issued a press release announcing that the
Naples, Florida manufacturing facilities of its Vitarich Laboratories, Inc.
subsidiary are fully operational after losing six days of production due to lack
of power and water utilities in the aftermath of Hurricane Wilma. The
unavailability of power and water utilities caused a decrease in the customer
shipments made at the end of the fiscal third quarter, and the decrease of
shipments will likely have a negative impact on the operating performance of
Vitarich in the fiscal third quarter. A copy of the Argan, Inc. press release is
attached to this report as Exhibit 99.1 and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d)   Exhibits.

            Exhibit No.       Description
            -----------       -----------

                99.1          Argan, Inc. Press Release issued October 31, 2005.


<PAGE>

                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date: November 1, 2005                         ARGAN, INC.

                                          By:  /s/ Rainer Bosselmann
                                               ---------------------------------
                                                   Rainer Bosselmann
                                                   Chairman of the Board and
                                                   Chief Executive Officer

<PAGE>

                                  EXHIBIT INDEX

            Exhibit No.       Description
            -----------       -----------

                99.1          Argan, Inc. Press Release issued October 31, 2005.

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v028103_ex99-1.txt
<TEXT>

                                                                    Exhibit 99.1

                                                           [LOGO OF ARGAN, INC.]

NEWS - FOR IMMEDIATE RELEASE

Date:       October 31, 2005
From:       Argan, Inc.
Contact:    Haywood Miller
Fax:        301-315-0064
Phone:      301-315-0027

           ARGAN ANNOUNCES THAT VITARICH MANUFACTURING FACILITIES ARE
           FULLY OPERATIONAL AFTER LOSING SIX DAYS OF PRODUCTION DUE
              TO LACK OF POWER IN THE AFTERMATH OF HURRICANE WILMA

Rockville, MD - Argan, Inc. (OTC; BSE: AGAX.PK; AGX) announces that the Naples,
FL manufacturing facilities of its Vitarich Laboratories, Inc. subsidiary are
fully operational after losing six days of production due to lack of power and
water utilities in the aftermath of Hurricane Wilma. Despite the plant
sustaining minimal damage in the storm, the unavailability of power and water
utilities over the past week caused a decrease in the customer shipments made at
the end of the fiscal third quarter. The decrease of shipments will likely have
a negative impact on the operating performance of Vitarich in the fiscal third
quarter. "The staff at Vitarich performed remarkably well given the difficult
circumstances of this storm. Unfortunately, the availability of water and power
was outside our control. The timing of the storm to coincide with the end of our
fiscal third quarter will have a negative impact on operations for the quarter,
but should have a negligible impact on our performance for the year." stated
Rainer Bosselmann.

Argan is a publicly traded holding company, focusing on companies that provide
products and services to growth industries. Vitarich Laboratories, a wholly
owned subsidiary of Argan located in Naples, FL, is a farm-to-market, vertically
integrated contract private label manufacturer of premium nutraceutical
products, including nutritional and whole-food dietary supplements and other
personal healthcare products. Argan has another wholly owned subsidiary,
Southern Maryland Cable, Inc., that provides inside premise wiring services to
the federal government and also provides underground and aerial construction
services and splicing to major telecommunications and utilities customers.

For more information on Argan, go to www.arganinc.com and to
www.vitarichlabs.com for more information on Vitarich Laboratories.

This press release contains certain-forward looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange act of 1934, as amended. Although Argan believes
the assumptions underlying the forward-looking statements contained herein,
including the development plans of Argan, are reasonable, any of the assumptions
could be inaccurate and therefore, there can be no assurance that the
forward-looking statements contained in the press release will prove to be
accurate. In light of significant uncertainties inherent in the forward-looking
statements included herein, the inclusion of such information should not be
regarded as a representation by Argan or any other person that the objectives
and plans of Argan will be achieved.
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
